BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1478368)

  • 1. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
    Zavala AV; Fabiano de Bruno LE; Cardoso AI; Mota AH; Capucchio M; Poskus E; Fainboim L; Basabe JC
    Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents.
    Colman PG; Harrison LC; Tait BD
    Aust N Z J Med; 1985 Apr; 15(2):209-12. PubMed ID: 3896215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A; Manrique M; Arteaga A; Acosta AM; Andrade L
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune response to diverse islet cell antigens in IDDM.
    Durinovic-Bellò I; Hummel M; Ziegler AG
    Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.
    Banerji MA; Chaiken RL; Huey H; Tuomi T; Norin AJ; Mackay IR; Rowley MJ; Zimmet PZ; Lebovitz HE
    Diabetes; 1994 Jun; 43(6):741-5. PubMed ID: 8194658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune-mediated disease and secondary failure to oral therapy in type 2 diabetes mellitus.
    Avilés-Santa L; Maclaren N; Raskin P
    J Diabetes Complications; 2004; 18(1):10-7. PubMed ID: 15019594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.
    Goday A; Motaña E; Ercilla G; Fernandez J; Gomis R; Vilardell E
    Acta Diabetol Lat; 1990; 27(3):215-22. PubMed ID: 2075784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes.
    Groop L; Groop PH; Koskimies S
    Diabetologia; 1986 Nov; 29(11):757-60. PubMed ID: 3545954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
    Durinovic-Belló I; Schlosser M; Riedl M; Maisel N; Rosinger S; Kalbacher H; Deeg M; Ziegler M; Elliott J; Roep BO; Karges W; Boehm BO
    Diabetologia; 2004 Mar; 47(3):439-450. PubMed ID: 14745491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.
    Vandewalle CL; Decraene T; Schuit FC; De Leeuw IH; Pipeleers DG; Gorus FK
    Diabetologia; 1993 Nov; 36(11):1155-62. PubMed ID: 8270130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
    Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
    Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.